GEN - Genetic Engineering & Biotech NewsOriginal article
How Preclinical Manufacturing Can De-Risk the Path to GMP-Ready Viral Vector Programs
ConferenceNeutral
AI Analysis
Summary
GEN is hosting a webinar featuring expert Chris Nieder discussing how preclinical manufacturing strategies can support the development of GMP-ready viral vector programs.
Importance:2/10
Sentiment:
0.00
viral vectorsmanufacturingGMPpreclinicalwebinar
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on October 8, 2026 8:45 PM